Cerebral Palsy
Gene: ACADM
Additional individual with a complex neurodevelopmental disorder including cerebral palsy and fatty liver with elevated ALT reported with compound heterozygous LP variants in ACADM (PMID: 38843839). Neurological sequelae including CP are a frequent outcome of untreated ACADMD.Created: 24 Jul 2024, 1:48 a.m. | Last Modified: 24 Jul 2024, 1:48 a.m.
Panel Version: 1.356
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Publications
Currently unclear if variants in this gene can cause CP. If so, CP is likely to happen as a secondary effect of the brain damage happening if Acyl-CoA dehydrogenase deficiency is not treated correctly or early enough.
According to one study, CP can be present in 9% of cases with biallelic mutations in ACADM, probably secondary to the underlying disease and associated with early-onset seizures (PMID 11263545).
In a second publication one other case of CP associated with biallelic mutations in ACADM was presented, but this patient's phenotype was likely caused by biallelic mutations in PDHX which were present simultaneously.
Sources: LiteratureCreated: 22 May 2023, 2:41 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Acyl-CoA dehydrogenase, medium chain, deficiency of, MIM# 201450
Publications
Publications for gene: ACADM were set to 11263545; 35076175
Gene: acadm has been classified as Green List (High Evidence).
Gene: acadm has been classified as Amber List (Moderate Evidence).
Gene: acadm has been classified as Amber List (Moderate Evidence).
gene: ACADM was added gene: ACADM was added to Cerebral Palsy. Sources: Literature Mode of inheritance for gene: ACADM was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ACADM were set to 11263545; 35076175 Phenotypes for gene: ACADM were set to Acyl-CoA dehydrogenase, medium chain, deficiency of, MIM# 201450 Review for gene: ACADM was set to AMBER